Literature DB >> 31106723

A national survey of testing and management of asymptomatic carriage of C. difficile.

Preeta K Kutty1, Susan E Beekmann2, Ronda L Sinkowitz-Cochran1, Erik R Dubberke3, David T Kuhar1, L Clifford McDonald1, Philip M Polgreen2.   

Abstract

A nationwide survey indicated that screening for asymptomatic carriers of C. difficile is an uncommon practice in US healthcare settings. Better understanding of the role of asymptomatic carriage in C. difficile transmission, and of the measures available to reduce that risk, are needed to inform best practices regarding the management of carriers.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31106723     DOI： 10.1017/ice.2019.109

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  3 in total

1.  Transmission Dynamics of Clostridioides difficile in 2 High-Acuity Hospital Units.

Authors:  Karim Khader; L Silvia Munoz-Price; Ryan Hanson; Vanessa Stevens; Lindsay T Keegan; Alun Thomas; Liliana E Pezzin; Ann Nattinger; Siddhartha Singh; Matthew H Samore
Journal:  Clin Infect Dis       Date:  2021-01-29       Impact factor: 9.079

2.  Reduced Clostridioides difficile infection in a pragmatic stepped-wedge initiative using admission surveillance to detect colonization.

Authors:  Lance R Peterson; Sean O'Grady; Mary Keegan; Adrienne Fisher; Shane Zelencik; Bridget Kufner; Mona Shah; Rachel Lim; Donna Schora; Sanchita Das; Kamaljit Singh
Journal:  PLoS One       Date:  2020-03-19       Impact factor: 3.240

3.  Factors Associated with Clostridioides (Clostridium) Difficile Infection and Colonization: Ongoing Prospective Cohort Study in a French University Hospital.

Authors:  Nagham Khanafer; Philippe Vanhems; Sabrina Bennia; Géraldine Martin-Gaujard; Laurent Juillard; Thomas Rimmelé; Laurent Argaud; Olivier Martin; Laetitia Huriaux; Guillaume Marcotte; Romain Hernu; Bernard Floccard; Pierre Cassier; Study Group
Journal:  Int J Environ Res Public Health       Date:  2021-07-15       Impact factor: 3.390
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.